Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US15859315Application Date: 2017-12-29
-
Publication No.: US10174003B2Publication Date: 2019-01-08
- Inventor: Young K. Chen , Zhe Nie , Jeffrey Alan Stafford , James Marvin Veal
- Applicant: Celgene Quanticel Research, Inc.
- Applicant Address: US CA San Diego
- Assignee: Celgene Quanticel Research, Inc.
- Current Assignee: Celgene Quanticel Research, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein LLP
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; C07D401/14 ; C07D405/14 ; C07D471/04

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted imidazole-pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase enzymes. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as pancreatic cancer, prostate cancer, breast cancer, bladder cancer, lung cancer, gastric cancer, leukemia and/or melanoma and the like.
Public/Granted literature
- US20180118720A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2018-05-03
Information query
IPC分类: